India Coronavirus Dispatch: Third wave inevitable, says AIIMS chief

Covid violations in Delhi hit two-month high, black fungus fatality rate greater than that of Covid in Karnataka, and more-news relevant to India's fight against the pandemic

Covid heath worker
A health worker exits an ambulance outside a quarantine center. (Photo: Bloomberg)
Bharath Manjesh New Delhi
3 min read Last Updated : Jun 19 2021 | 2:03 PM IST

Over 60,000 fresh cases reported

 

India reported 60,753 fresh coronavirus infections on Saturday, taking the cumulative caseload to 29.8 million, according to central health ministry data. The country saw 1,647 deaths due to the pandemic, taking the death toll to 385,137. The active caseload is at 760,019, while the total recoveries have surged to 28.6 million. As many as 272.3 million vaccine shots have been administered since the nationwide inoculation programme kicked off on January 16. Of these, 3.3 million were given on Friday. Read more

 

 

Third wave could hit India in 6-8 weeks: AIIMS chief

Also Read

 

AIIMS chief Randeep Guleria told NDTV that a third Covid-19 wave in India is "inevitable" and could hit the country in the next six to eight weeks. The remark came amid unlocking in parts of the country after weeks of strict restrictions. Guleria believes India's biggest challenge is to inoculate a large population, and the increase in vaccine dose interval for Covishield "may not be a bad" approach to cover more people. He stressed that the mutation of the virus needs to be closely studied as he talked about the new Delta-Plus variant, which has evolved from the Delta variant. Read more

 

 

As Delhi unlocks, Covid violations hit two-month high

 

The number of tickets issued for violation of Covid-mandated behaviour has risen to a two-month peak in recent days as the six-week-long lockdown in Delhi has eased, a report in The Indian Express said. As many as 5,301 people were issued tickets on Thursday for violations such as stepping out without masks, wearing masks improperly, spitting, and not maintaining social distancing. Close to 2,500 people were being given tickets every day till the last week of May when the lockdown was in place. Over the past two months, 189,307 such tickets have been issued—at an average of 3,053 per day. Read more

 

 

Karnataka: Mucormycosis fatality rate greater than that of Covid

 

The mortality rate of "black fungus" or mucormycosis, a post-Covid complication, is higher than that of Covid in Karnataka, a report in The Hindu said. While the State’s case fatality rate (CFR) for Covid is 1.2%, the mortality rate from mucormycosis has touched 7.8%. Till June 17, it had claimed 225 lives of the total 2,856 persons infected. Bhujang Shetty, chairman of Narayana Nethralaya and member of the State’s expert committee on mucormycosis, said there was no need to panic as the root cause of the condition was uncontrolled diabetes. Read more

 

 

Two first-dose vaccine certificates can be merged to get final one

 

The Centre has introduced a new feature on Co-Win to merge two first dose certificates to get a final one, a report in the Times of India said. This brings relief to many vaccine recipients who had received two doses using different cellphone numbers, which count as two first doses on the Co-Win platform. Now, users can log in on Co-Win with their registered cellphone number, click on “Raise an issue” option, select “Merge multiple first dose provisional certificates” and follow the listed steps to get the final vaccination certificate. Read more

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story